21.04.2020 Novavax Inc Daily Analysis

21.04.2020 Novavax Inc Daily Analysis

Novavax Inc (NVAX) 23.80usd ,+4.72,+24.74% Novavax announced last week on April 16 that it will start a COVID-19 vaccine called SARS-CoV-2 Recombinant Spike Protein Nanoparticle, NVX-CoV2373 within the coming weeks with the Nucleus company in Australia. The reason why the stock skyrocketed with 24% is that the investors are really looking forward to the success of the vaccine trials, therefore, these gains are attributed to the announcement of last week which is still in play even today as it is trading 23.80usd. Novavax's stock has become a big play of the COVID-19 pandemic and the stock gained its value just after when the company announced positive results of its influenza candidate which was tried and tested in the old age around 65 years old.